Brookstone Capital Management Purchases Shares of 2,992 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Brookstone Capital Management purchased a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 2,992 shares of the exchange traded fund’s stock, valued at approximately $284,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in XBI. Sectoral Asset Management Inc. grew its holdings in SPDR S&P Biotech ETF by 36.8% during the third quarter. Sectoral Asset Management Inc. now owns 24,675 shares of the exchange traded fund’s stock valued at $1,802,000 after purchasing an additional 6,643 shares during the last quarter. Scotia Capital Inc. grew its holdings in SPDR S&P Biotech ETF by 4.9% during the third quarter. Scotia Capital Inc. now owns 41,137 shares of the exchange traded fund’s stock valued at $3,004,000 after purchasing an additional 1,933 shares during the last quarter. Ramirez Asset Management Inc. bought a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $100,000. Integrated Wealth Concepts LLC boosted its position in shares of SPDR S&P Biotech ETF by 9.3% in the third quarter. Integrated Wealth Concepts LLC now owns 23,656 shares of the exchange traded fund’s stock valued at $1,727,000 after acquiring an additional 2,021 shares during the period. Finally, Advisors Capital Management LLC boosted its position in shares of SPDR S&P Biotech ETF by 5.7% in the third quarter. Advisors Capital Management LLC now owns 4,563 shares of the exchange traded fund’s stock valued at $333,000 after acquiring an additional 248 shares during the period.

SPDR S&P Biotech ETF Trading Down 1.8 %

XBI opened at $91.36 on Wednesday. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52. The stock has a market capitalization of $6.96 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The business has a 50 day moving average of $90.27 and a 200-day moving average of $90.94.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.